Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
George K Ng is Chief Executive Officer at Processa Pharmaceuticals. OQRO lists 12 transactions filed with the SEC under this name, the latest on Aug 12, 2026, each linked to the official Form 4.
Chief Executive Officer
Disclosures on record
12
Companies involved
2
7 buys, median −26.0 pts vs S&P 500, beat it 0 of 7 times.
Average −27.5 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Jan 29, 2025 to Jul 2, 2026, measured from the first close after the filing. Past results, not a forecast.
7 purchases disclosed; 0% of the 7 measured at 90 days finished ahead of the index. $1,000 placed after each of the 6 purchases disclosed since 2025-11-16 would be worth $4.5K today ($6K put in); the same in the S&P 500 (SPY): $6.1K.
Not ranked: fewer than 10 purchases measured at 90 days. The middle of the 82 ranked insiders is −5.5 pts (median, against the S&P 500).
Processa PharmaceuticalsPCSA
11 disclosures · Jan 2025 – Aug 2026 · 8 bought
Aug 8, 20261,600disclosed Aug 12
DetailsOfficial recordAug 8, 20261,600disclosed Aug 12
DetailsEqual weight counts every purchase once; by size counts it for its disclosed dollars. Both are measured from the first close after it was reported. Past results describe the past, not a forecast. How this is measured · Leaderboard
Jul 26, 20269,384disclosed Jul 29
DetailsOfficial recordJul 1, 2026Bought~$5.9Kdisclosed Jul 2
DetailsOfficial recordJun 15, 2026Bought~$5.5Kdisclosed Jun 17
DetailsOfficial recordMay 29, 2026Bought~$5.5Kdisclosed Jun 2
DetailsOfficial recordMay 15, 2026Bought~$5.5Kdisclosed May 20
DetailsOfficial recordApr 15, 2026Bought~$5.5Kdisclosed May 20
DetailsOfficial recordApr 30, 2026Bought~$5.5Kdisclosed May 2
DetailsOfficial recordMar 31, 2026Bought~$5.4Kdisclosed May 1
DetailsOfficial recordJan 27, 2025Bought~$70Kdisclosed Jan 29
DetailsOfficial recordFeb 12, 2026156Kdisclosed Feb 17
DetailsOfficial recordGeorge K Ng bought shares on the open market in 2024, 2025 and 2026.
George K Ng reported 9 open-market purchases and 0 sales since 2024; purchases in 3 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $39K7×7 trades | — |
| 2025 | $70K1×1 trade | — |
| 2024 | $27K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
As of the latest filing on , George K Ng reported holding 104,292 shares of Processa Pharmaceuticals (PCSA), worth about $179K at the last close of $2 (Nov 16, 2026): 17,092 held directly and 87,200 through a george ng irra fbo: george ng. In the last 12 months, George K Ng bought $39K in 7 open-market purchases.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Processa Pharmaceuticals PCSA | 104,292 | 17K direct · 87K george ng irra fbo: george ng | $2 | $179K | Aug 8, 2026 |
Is this George K Ng’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Aug 8, 2026, George K Ng reported holding 104,292 shares of Processa Pharmaceuticals (PCSA), of which 87,200 are held indirectly. At the last close of $2 on Nov 16, 2026, that is about $179K. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, George K Ng reported 7 open-market purchases worth $39K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
George K Ng bought shares on the open market in 2024, 2025 and 2026.
In SEC filings since 2024: the latest open-market purchase is from 2026; no open-market sale is on record.
Processa Pharmaceuticals (PCSA), from 2024 to 2026: 9 purchases and 0 sales.
George K Ng reported 9 open-market purchases and 0 sales here, 2024 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.